Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
International Journal of Hematology
|
June 10, 2000
Ex vivo expansion of megakaryocytic cells
A M Maurer, Y Liu, J P Caen, et al.
Bio-Medical Materials and Engineering
|
April 5, 2017
New insights into the heterogeneity and functional diversity of human mesenchymal stem cells
Z C Han, W J Du, Z B Han, et al.
International Journal of Hematology
|
November 6, 1998
The tetrapeptide AcSDKP reduces the sensitivity of murine CFU-MK and CFU-GM progenitors to aracytine in vitro and in vivo
S Aidoudi, M Guigon, V Drouet, et al.
British Journal of Haematology
|
November 1, 1994
Interleukin-3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG-01 cells
Y Z Chen, X F Gu, J P Caen, et al.
The Journal of Laboratory and Clinical Medicine
|
February 1, 1996
Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines
I Lebeurier, L Raclet, J Amiral, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
May 1, 1986
[Clinical observation on the changes in plasma cyclic nucleotides in patients with leukemia before and after treatment and their relation to cell-mediated immunity]
Z C Han, L H Lu, X M Zhang, et al.
Blood
|
May 23, 1998
Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization
C Perollet, Z C Han, C Savona, et al.
British Journal of Haematology
|
September 1, 1996
In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil
S Aidoudi, M Guigon, I Lebeurier, et al.
International Journal of Cell Cloning
|
July 1, 1990
Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III)
Z C Han, S Bellucci, A Walz, et al.
Journal of Biological Regulators and Homeostatic Agents
|
July 1, 1988
Increased fibroblast colony stimulating activity (F-CSA) in serum of myeloproliferative disorders
Z C Han, J Briere, D Parent, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
International Journal of Hematology
|
June 10, 2000
Ex vivo expansion of megakaryocytic cells
A M Maurer, Y Liu, J P Caen, et al.
Bio-Medical Materials and Engineering
|
April 5, 2017
New insights into the heterogeneity and functional diversity of human mesenchymal stem cells
Z C Han, W J Du, Z B Han, et al.
International Journal of Hematology
|
November 6, 1998
The tetrapeptide AcSDKP reduces the sensitivity of murine CFU-MK and CFU-GM progenitors to aracytine in vitro and in vivo
S Aidoudi, M Guigon, V Drouet, et al.
British Journal of Haematology
|
November 1, 1994
Interleukin-3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG-01 cells
Y Z Chen, X F Gu, J P Caen, et al.
The Journal of Laboratory and Clinical Medicine
|
February 1, 1996
Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines
I Lebeurier, L Raclet, J Amiral, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
May 1, 1986
[Clinical observation on the changes in plasma cyclic nucleotides in patients with leukemia before and after treatment and their relation to cell-mediated immunity]
Z C Han, L H Lu, X M Zhang, et al.
Blood
|
May 23, 1998
Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization
C Perollet, Z C Han, C Savona, et al.
British Journal of Haematology
|
September 1, 1996
In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil
S Aidoudi, M Guigon, I Lebeurier, et al.
International Journal of Cell Cloning
|
July 1, 1990
Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III)
Z C Han, S Bellucci, A Walz, et al.
Journal of Biological Regulators and Homeostatic Agents
|
July 1, 1988
Increased fibroblast colony stimulating activity (F-CSA) in serum of myeloproliferative disorders
Z C Han, J Briere, D Parent, et al.
Page
of 8